Otolaryngology · 2014 · 90 citations · 22 references
MedicineOtolaryngologySurgeryPulmonologyRespiratory PharmacotherapyRhinologyChronic RhinosinusitisEndoscopic Sinus SurgeryNasal PolypsAspirin-exacerbated Respiratory Disease TreatmentCase Series ReviewLong-term Symptom ControlMedical Chart ReviewNasal Polyp AssessmentPolyp Grade ClassificationRetrospective Record ReviewSinonasal Endoscopy
OBJECTIVE: This study aimed to assess sinonasal outcomes in patients with aspirin exacerbated respiratory disease (AERD) undergoing aspirin desensitization following endoscopic sinus surgery (ESS). STUDY DESIGN: Case series with chart review. SETTING: University hospital. SUBJECTS AND METHODS: A retrospective review of sinonasal outcomes was conducted for 30 AERD patients undergoing aspirin desensitization and maintenance therapy following ESS. Sinonasal outcomes were prospectively assessed by the Sinonasal Outcomes Test-22 (SNOT-22) and endoscopic polyp grading system. Data were collected preoperatively, 1 and 4 weeks postsurgery (before desensitization), and 1, 6, 12, 18, 24, and 30 months after aspirin desensitization. RESULTS: Twenty-eight of 30 patients (93.3%) successfully completed aspirin desensitization, whereas 2 of 30 (6.7%) were unable to complete desensitization due to respiratory intolerance. Of the 21 patients who successfully completed a minimum of 24 weeks of follow-up, 20 (95.2%) patients demonstrated sustained endoscopic and symptomatic improvement for a median follow-up period of 33 months. After surgical treatment but before desensitization, patients experienced significant reductions in SNOT-22 and polyp grade scores. In the first 6 months after aspirin desensitization, patients experienced further significant reductions in SNOT-22 scores, whereas polyp grade remained stable. The improvements in symptom endoscopic scores were preserved throughout the follow-up period after desensitization. No patients required additional sinus surgery. One patient had to discontinue aspirin therapy due to gastrointestinal side effects. No other adverse reactions to aspirin were noted. CONCLUSION: Aspirin desensitization following ESS appears to be a well-tolerated and effective adjunctive therapy for long-term control of nasal polyposis in patients with AERD.
22
Psychometric validity of the 22‐item Sinonasal Outcome Test
Claire Hopkins, S. Gillett, R Slack et al. · Clinical Otolaryngology · 2009 · 1.6K citations
Medicine, Otolaryngology, Surgery +16
V J Lund, I S Mackay · PubMed · 1993 · 1.5K citations
Max Samter · Annals of Internal Medicine · 1968 · 834 citations
Medicine, Immunology, Pharmacology +12
Rhinosinusitis: Developing guidance for clinical trials
Daniel L. Hamilos, James A. Hadley, Donald C. Lanza et al. · Journal of Allergy and Clinical Immunology · 2006 · 348 citations
Medicine, Otolaryngology, Allergy +11
María Pilar Berges‐Gimeno, Ronald A. Simon, Donald D. Stevenson · Journal of Allergy and Clinical Immunology · 2003 · 333 citations · Full text